Table 2 Association between HAART combinations during pregnancy and newborn infection
From: Mother-to-child transmission of human immunodeficiency virus in aten years period
Newborn infection | With | Without | P* | RR | IC 95% | ||
|---|---|---|---|---|---|---|---|
N | % | n | % | ||||
Antiretroviral therapy | 0.0478 | ||||||
AZT Monotherapy | 3 | 14.3 | 18 | 85.7 | 1.00 | ||
NRTI+NRTI | 0 | 0.0 | 14 | 100 | NC | ||
NRTI+NRTI+NVP | 5 | 3.9 | 124 | 96.1 | 0.27 | 0.07-1.05 | |
NRTI+NRTI+NFV | 3 | 2.3 | 125 | 97.7 | 0.16 | 0.04-0.63 | |
NRTI+NRTI+LPV/R | 1 | 1.6 | 63 | 98.4 | 0.11 | 0.01-0.99 | |
Other PI regimens | 1 | 4.3 | 22 | 95.7 | 0.30 | 0.03-2.70 | |